Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR | Market Cap | 589.52B +63.3% |
| Revenue (ttm) | 165.10B +18.3% |
| Net Income | 10.65B |
| EPS | 37.74 |
| Shares Out | 282.20M |
| PE Ratio | 55.35 |
| Forward PE | 25.52 |
| Dividend | 5.00 (0.23%) |
| Ex-Dividend Date | Oct 3, 2025 |
| Volume | 408,786 |
| Average Volume | 594,468 |
| Open | 2,170.00 |
| Previous Close | 2,180.10 |
| Day's Range | 2,079.90 - 2,170.00 |
| 52-Week Range | 1,336.00 - 2,297.90 |
| Beta | 0.29 |
| RSI | 47.89 |
| Earnings Date | May 22, 2026 |
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally. The company provides branded, OTC, and generic formulations in the therapeutic areas of dermatology, respiratory, oncology, immunology, pain management, hypertension, central nervous system, cardiology, diabetes, contraceptives, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injec... [Read more]
Financial Performance
Financial StatementsNews
Pharma sector stocks today, March 23: Alembic Pharma down 2.24%, Ajanta Pharma falls 1.85%, Glenmark Pharma falls 1.98%
The pharmaceutical sector in India experienced a downturn on March 23, 2026, as reflected in early morning trading data from BSE and NSE around 9:29-9:30 AM IST. Most listed pharma…
Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2%
Pharmaceutical stocks in India experienced a decline on March 19, 2026, during early trading hours. Market data as of approximately 9:46 AM IST (BSE) and 9:49 AM IST (NSE) showed…
Glenmark Pharmaceuticals launches authorised generic to Savella tablets in the US
Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Limited, has announced the launch of Milnacipran Hydrochloride Tablets in the US market. These tablets, available in dosage...
Glenmark Pharmaceuticals receives US FDA approval for Fluticasone Propionate Nasal Spray
Glenmark Pharmaceuticals Limited has announced that it has received final approval from the United States Food & Drug Administration (U.S. FDA) for its Fluticasone Propionate Nasal Spray USP, 50 mcg…
Pharma sector stocks today, March 16: Suven Life up 3.46%, Glenmark Pharma surge 1.39%, Divis Lab rises 0.36%
The pharmaceutical sector stocks in India showed mixed performance on March 16, 2026, during early trading hours. Data is based on prices as of approximately 9:43 AM IST for BSE…
Pharma sector stocks today, March 11: Natco Pharma falls 1.35%, Alembic Pharma surge 1.33%, Glenmark Pharma up 1.41%
The Pharmaceuticals sector stocks in India showed mixed performance on March 11, 2026, during early trading hours. Data is based on prices as of approximately 9:43 AM IST for BSE…
Pharma sector stocks surge today, March 10: Natco Pharma up 4%, Granules India jumps 3.31%, Glenmark Pharma rises 2.72%
The pharmaceutical sector in India showed positive movement on March 10, 2026, during early trading hours, with many stocks recording gains as of approximately 9:36 AM IST on BSE and…
Pharma sector fall sharply otday, March 9: Laurus Labs down 3%, Glenmark Pharma drops 2.44%, Zydus Life falls 2.10%
The Indian pharmaceutical sector experienced declines on March 9, 2026, amid broader market weakness. As of approximately 9:36-9:39 AM IST, most listed pharma stocks traded lower on both BSE and…
Glenmark Pharma subsidiary gets US FDA approves Fluticasone Propionate inhalation aerosol with 180-day exclusivity
Glenmark Pharmaceuticals is likely to remain in focus after its subsidiary, Glenmark Specialty SA, received final approval from the United States Food and Drug Administration (US FDA) for Fluticasone ...
Glenmark Pharma’s US arm to launch Sodium Phosphates Injection USP
Glenmark Pharmaceuticals Inc., the US arm of Glenmark Pharmaceuticals Ltd., has announced the upcoming launch of Sodium Phosphates Injection USP...
Pharma sector stocks today, Feb 9: Marksans Pharma up 5%, Shilpa Medicare jumps 6%, Glenmark rises 1.83%
The Indian pharma sector showed mixed intraday movements on February 9, 2026, amid broader market gains driven by positive global...
AcuCort Signs Glenmark Deal To Market Zeqmelit In Six European Countries
(RTTNews) - AcuCort AB (ACUC.ST), a Swedish biotechnology company, on Thursday said it has signed a commercial agreement with Glenmark Pharmaceuticals Ltd. (GLENMARK.NS) for the marketing and distribu...
Pharma sector stocks fall today: Glenmark Pharma drops 1.38%, Aurobindo Pharma downm 1.25%, Sun Pharma falls 0.87, Dr. Reddy’s Lab down 0.48%
The pharma sector stocks in India experienced declines as of 10 AM on January 20, 2026, aligning with broader market...
Pharma sector stocks today: Sun Pharma falls 1.20%, Lupin down 1%, Glenmark Pharma rises 0.49%
The Indian pharma sector showed modest downward pressure in early trading on January 14, 2026, as of approximately 9:55 AM...
Pharma sector stocks today: Glenmark Pharma falls 2.41%, Dr Reddy’s Laboratories down 1.39%, Emcure up 1.70%
The Indian pharma sector displayed mixed performance in early trading on January 13, 2026, as of approximately 9:50 AM IST....
Glenmark Pharma launches Epinephrine Injection USP multiple-dose vial in the US
Glenmark Pharmaceuticals Inc. has announced the launch of Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial in the...
Top stocks to watch today, December 17: Ola Electric, NBCC, Ahluwalia Contracts, Glenmark Pharma, BEML and more
Indian equity benchmarks are expected to open on a flat note on Wednesday, December 17, 2025, as investors weigh mixed...
Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib
Glenmark Pharmaceuticals has taken a major step in strengthening its global oncology portfolio through its wholly owned subsidiary, Glenmark Specialty...
Glenmark Pharma to launch Leucovorin Calcium for Injection USP, 350 mg/vial in the U.S. market
Glenmark Pharmaceuticals Inc., USA has announced that it is gearing up to launch Leucovorin Calcium for Injection USP, 350 mg/vial...
Glenmark’s Aurangabad Facility Clears US FDA Inspection With Zero Observations
Glenmark Pharmaceuticals has received a major regulatory boost as the US Food and Drug Administration (US FDA) has successfully completed...
Glenmark Pharma receives US FDA EIR with VAI status for Monroe facility
Glenmark Pharmaceuticals Ltd announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration...
Glenmark Pharma launches world’s first bebulized triple therapy for COPD in India
Glenmark Pharmaceuticals Ltd., a global, research-driven pharmaceutical company, has announced the launch of Nebzmart® GFB Smartules® and Glenmark Airz® FB...
HSBC cuts Glenmark’s target price to Rs 2,110, says abnormal quarter driven by upfront ISB payment and India disruption
HSBC has maintained its buy rating on Glenmark Pharma while trimming its target price to ₹2,110, noting that the company’s...
Why Glenmark Pharma shares are falling nearly 5% today: explained
Shares of Glenmark Pharmaceuticals fell sharply by nearly 5% to Rs 1,811.60 on Monday, November 17, as investors reacted to...
Top Q2 results today, November 14: Tata Motors PV, Oil India, Glenmark Pharma, MRF and more to announce earnings
Several listed companies are set to declare their financial results for the quarter ended September 2025 on Friday, November 14....